ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Ratio Therapeutics
The Senior Scientist, Analytical Development at Ratio Therapeutics will lead the development and optimization of analytical quality control methods, transitioning early-phase methods to GMP/GLP compliant processes and supporting technology transfer to manufacturing sites. The role involves authoring regulatory documentation, training QC personnel, and ensuring compliance with GMP, GLP, and data integrity standards.
Headquarters
Boston, Massachusetts, United States
Company Size
11-50 employees
Founded
2021
Ratio Therapeutics is a discovery-to-early-clinical-stage biopharmaceutical company developing targeted radiopharmaceuticals for cancer patients. Its proprietary Trillium™ targeting scaffold combines pharmacokinetic modulation with advanced chelation to generate small-molecule targeting agents that selectively deliver therapeutic radioisotopes to tumors. The company advances candidates through preclinical and early clinical studies aiming to create best-in-class targeted radiotherapeutics with improved tumor targeting and safety. Ratio focuses on innovative chemistry and translational development to bring new radioligand therapies to patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Ratio Therapeutics.
29% above the average for this role